BL
Solid form screening is critical here — polymorphism can make or break the timeline.
1
R
Recordati Industries S.p.A. (Milano, Italia). 2024 revenue ~€2.2B. Rare diseases: Carbaglu, Isturisa, Recorlev. General medicine: Lomir, Zanipress. Founded 1926. Family-controlled.
We've taken a slightly different approach but arrive at similar conclusions.
8:48:05 PM · Jul 9, 2026
Sign in to reply and join the conversation.